Your browser doesn't support javascript.
loading
Experience with Optical Coherence Tomography Enhanced by a Novel Software (Ultreon™ 1.0 Software)-The First One Hundred Cases.
Bartus, Stanislaw; Silka, Wojciech; Kasprzycki, Karol; Sabatowski, Karol; Malinowski, Krzysztof Piotr; Rzeszutko, Lukasz; Chyrchel, Michal; Bryniarski, Leszek; Surdacki, Andrzej; Bartus, Krzysztof; Januszek, Rafal.
Afiliación
  • Bartus S; Department of Cardiology and Cardiovascular Interventions, University Hospital, 30-688 Kraków, Poland.
  • Silka W; Institute of Cardiology, Jagiellonian University Medical College, 31-202 Kraków, Poland.
  • Kasprzycki K; Students' Scientific Group, the Second Department of Cardiology, Jagiellonian University Medical College, 31-034 Kraków, Poland.
  • Sabatowski K; Department of Cardiology and Cardiovascular Interventions, University Hospital, 30-688 Kraków, Poland.
  • Malinowski KP; Department of Cardiology and Cardiovascular Interventions, University Hospital, 30-688 Kraków, Poland.
  • Rzeszutko L; Faculty of Medicine, Department of Bioinformatics and Telemedicine, Jagiellonian University Medical College, 31-530 Kraków, Poland.
  • Chyrchel M; Center for Digital Medicine and Robotics, Jagiellonian University Medical College, 31-530 Kraków, Poland.
  • Bryniarski L; Department of Cardiology and Cardiovascular Interventions, University Hospital, 30-688 Kraków, Poland.
  • Surdacki A; Institute of Cardiology, Jagiellonian University Medical College, 31-202 Kraków, Poland.
  • Bartus K; Department of Cardiology and Cardiovascular Interventions, University Hospital, 30-688 Kraków, Poland.
  • Januszek R; Institute of Cardiology, Jagiellonian University Medical College, 31-202 Kraków, Poland.
Medicina (Kaunas) ; 58(9)2022 Sep 05.
Article en En | MEDLINE | ID: mdl-36143904
Introduction: Optical coherence tomography (OCT) intravascular imaging including the latest version Ultreon™ 1.0 Software (Abbott Vascular, Santa Clara, CA, USA), not only improve patients prognosis, but also facilitates improved percutaneous coronary intervention (PCI). Objectives: The aim of the study was to compare procedure related decision making, procedural indices, clinical outcomes according to the extent of stent expansion and assess risk factors of underexpansion in patients treated with PCI using OCT. Methods: The study comprised 100 patients, which were divided in groups according to the extent of stent expansion: <90 (29 patients) and ≥90% (71 patients). Comparison of OCT parameters, selected clinical and procedural characteristics was performed between groups. We assessed clinical outcomes during the follow-up: major adverse cardiovascular events and risk factors of stent underexpansion. Results: Patients from the stent underexpansion group were treated more often in the past with percutaneous peripheral interventions (p=0.02), no other significant differences being noted in general characteristics, procedural characteristics or clinical outcomes comparing both groups. Significant predictors of stent underexpansion assessed by simple linear univariable analysis included: hypercholesterolemia, obstructive bronchial diseases and treatment with inhalators, family history of cardiovascular disease, PCI of other than the left main coronary artery, stent and drug-eluting stent implantation, PCI without drug-eluting balloon, paclitaxel antimitotic agent, greater maximal stent diameter and lower mean Euroscore II value. Univariable logistic regression analysis revealed a correlation between stent underexpansion and greater creatinine serum concentration before [OR: 0.97, 95%CI: 0.95-0.99, p=0.01] and after PCI [OR: 0.98, 95%CI: 0.96-0.99, p=0.02]. Conclusions: Based on the presented analysis, the degree of stent expansion is not related to the selected procedural, OCT imaging indices and clinical outcomes. Logistic regression analysis confirmed such a relationship for creatinine level.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedad de la Arteria Coronaria / Antimitóticos / Stents Liberadores de Fármacos / Intervención Coronaria Percutánea Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Medicina (Kaunas) Asunto de la revista: MEDICINA Año: 2022 Tipo del documento: Article País de afiliación: Polonia Pais de publicación: Suiza

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedad de la Arteria Coronaria / Antimitóticos / Stents Liberadores de Fármacos / Intervención Coronaria Percutánea Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Medicina (Kaunas) Asunto de la revista: MEDICINA Año: 2022 Tipo del documento: Article País de afiliación: Polonia Pais de publicación: Suiza